Trials / Unknown
UnknownNCT05490082
Mirabegron, Propevirine, Solifenacin for Treatment of Lower Urinary Tract Symptoms During Intravesical BCG Instillation
Mirabegron, Propevirine, Solifenacin for Treatment of Lower Urinary Tract Symptoms During Intravesical BCG Instillation: Prospective Randomized Controlled Trial
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Mansoura University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A randomized controlled study to compare the efficacy of mirabegron, solifenacin and propevirine for treatment of Lower urinary tract symptoms during intravesical BCG installation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mirabegron, Propevirine, Solifenacin | Efficacy comparison |
Timeline
- Start date
- 2022-03-01
- Primary completion
- 2023-03-01
- Completion
- 2023-10-01
- First posted
- 2022-08-05
- Last updated
- 2022-08-05
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05490082. Inclusion in this directory is not an endorsement.